Nasdaq:US$13.22 (-0.05) | HKEX:HK$20.95 (-0.35) | AIM:£2.13 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases | 16 Apr 2023

AACR 2023: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2